Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Betamethasone sodium phosphate
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Betamethasone 0.1% ear/eye/nose drops
1104010D0AAAGAG
|
Betamethasone sodium phosphate (Ear/Eye/Nasal) | Betamethasone sodium phosphate | Eye | 41,459 |
|
Betamethasone 500microgram soluble tablets sugar free
0603020C0AAABAB
|
Betamethasone sodium phosphate (Systemic) | Betamethasone sodium phosphate | Endocrine System | 17,600 |
|
Betamethasone 0.1% / Neomycin 0.5% ear/eye/nose drops
1201010E0AAABAB
|
Betamethasone sodium phosphate (Ear) | Betamethasone sodium phosphate | Ear, Nose and Oropharynx | 9,962 |
|
Betnesol 0.1% eye/ear/nose drops
1104010D0BBAAAG
|
Betnesol (Ear/Eye/Nasal) | Betamethasone sodium phosphate | Eye | 8,945 |
|
Betnesol-N ear/eye/nose drops
1201010E0BBAAAB
|
Betnesol-N | Betamethasone sodium phosphate | Ear, Nose and Oropharynx | 3,517 |
|
Vistamethasone 0.1% ear/eye/nose drops
1104010D0BCAAAG
|
Vistamethasone | Betamethasone sodium phosphate | Eye | 1,767 |
|
Betnesol 500microgram soluble tablets
0603020C0BBAAAB
|
Betnesol (Systemic) | Betamethasone sodium phosphate | Endocrine System | 14 |
|
Betamethasone 4mg/1ml solution for injection ampoules
0603020C0AAAAAA
|
Betamethasone sodium phosphate (Systemic) | Betamethasone sodium phosphate | Endocrine System | 7 |
|
Betamethasone 0.1% eye ointment
1104010D0AAABAB
|
Betamethasone sodium phosphate (Ear/Eye/Nasal) | Betamethasone sodium phosphate | Eye | No data available |
|
Betnesol 0.1% eye ointment
1104010D0BBABAB
|
Betnesol (Ear/Eye/Nasal) | Betamethasone sodium phosphate | Eye | No data available |
|
Betnesol 4mg/1ml solution for injection ampoules
0603020C0BBABAA
|
Betnesol (Systemic) | Betamethasone sodium phosphate | Endocrine System | No data available |
|
Betnesol-N eye ointment
1104010D0BBACAD
|
Betnesol (Ear/Eye/Nasal) | Betamethasone sodium phosphate | Eye | No data available |
|
Neomycin 0.5% / Betamethasone 0.1% eye ointment
1104010D0AAADAD
|
Betamethasone sodium phosphate (Ear/Eye/Nasal) | Betamethasone sodium phosphate | Eye | No data available |
|
Vistamethasone N ear/eye/nose drops
1201010E0BCAAAB
|
Vistamethasone N | Betamethasone sodium phosphate | Ear, Nose and Oropharynx | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.